124 research outputs found

    From Current to Constituent Quarks: a Renormalization Group Improved Hamiltonian-based Description of Hadrons

    Get PDF
    A model which combines the perturbative behavior of QCD with low energy phenomenology in a unified framework is developed. This is achieved by applying a similarity transformation to the QCD Hamiltonian which removes interactions between the ultraviolet cutoff and an arbitrary lower scale. Iteration then yields a renormalization group improved effective Hamiltonian at the hadronic energy scale. The procedure preserves the standard ultraviolet behavior of QCD. Furthermore, the Hamiltonian evolves smoothly to a phenomenological low energy behavior below the hadronic scale. This method has the benefit of allowing radiative corrections to be directly incorporated into nonperturbative many-body techniques. It is applied to Coulomb gauge QCD supplemented with a low energy linear confinement interaction. A nontrivial vacuum is included in the analysis via a Bogoliubov-Valatin transformation. Finally, the formalism is applied to the vacuum gap equation, the quark condensate, and the dynamical quark mass.Comment: 36 pages, RevTeX, 5 ps figures include

    Nonperturbative Renormalization and the QCD Vacuum

    Full text link
    We present a self consistent approach to Coulomb gauge Hamiltonian QCD which allows one to relate single gluon spectral properties to the long range behavior of the confining interaction. Nonperturbative renormalization is discussed. The numerical results are in good agreement with phenomenological and lattice forms of the static potential.Comment: 23 pages in RevTex, 4 postscript figure

    Magnetotransport in two-dimensional electron gas at large filling factors

    Full text link
    We derive the quantum Boltzmann equation for the two-dimensional electron gas in a magnetic field such that the filling factor ν1\nu \gg 1. This equation describes all of the effects of the external fields on the impurity collision integral including Shubnikov-de Haas oscillations, smooth part of the magnetoresistance, and non-linear transport. Furthemore, we obtain quantitative results for the effect of the external microwave radiation on the linear and non-linear dcdc transport in the system. Our findings are relevant for the description of the oscillating resistivity discovered by Zudov {\em et al.}, zero-resistance state discovered by Mani {\em et al.} and Zudov {\em et al.}, and for the microscopic justification of the model of Andreev {\em et al.}. We also present semiclassical picture for the qualitative consideration of the effects of the applied field on the collision integral.Comment: 28 pages, 19 figures; The discussion of the role of the effect of the microwave field on the distribution function is revised (see also cond-mat/0310668). Accepted in Phys. Rev.

    Fourteen Months of Observations of the Possible Super-Chandrasekhar Mass Type Ia Supernova 2009dc

    Full text link
    In this paper, we present and analyse optical photometry and spectra of the extremely luminous and slowly evolving Type Ia supernova (SN Ia) 2009dc, and offer evidence that it is a super-Chandrasekhar mass (SC) SN Ia and thus had a SC white dwarf (WD) progenitor. Optical spectra of SN 2007if, a similar object, are also shown. SN 2009dc had one of the most slowly evolving light curves ever observed for a SN Ia, with a rise time of ~23 days and Delta m_15(B) = 0.72 mag. We calculate a lower limit to the peak bolometric luminosity of ~2.4e43 erg/s, though the actual value is likely almost 40% larger. Optical spectra of SN 2009dc and SN 2007if obtained near maximum brightness exhibit strong C II features (indicative of a significant amount of unburned material), and the post-maximum spectra are dominated by iron-group elements. All of our spectra of SN 2009dc and SN 2007if also show low expansion velocities. However, we see no strong evidence in SN 2009dc for a velocity "plateau" near maximum light like the one seen in SN 2007if (Scalzo et al. 2010). The high luminosity and low expansion velocities of SN 2009dc lead us to derive a possible WD progenitor mass of more than 2 M_Sun and a Ni-56 mass of about 1.4-1.7 M_Sun. We propose that the host galaxy of SN 2009dc underwent a gravitational interaction with a neighboring galaxy in the relatively recent past. This may have led to a sudden burst of star formation which could have produced the SC WD progenitor of SN 2009dc and likely turned the neighboring galaxy into a "post-starburst galaxy." No published model seems to match the extreme values observed in SN 2009dc, but simulations do show that such massive progenitors can exist (likely as a result of the merger of two WDs) and can possibly explode as SC SNe Ia.Comment: 30 pages, 16 figures, 8 tables, re-submitted to MNRA

    Unconscious Thinking, Feeling and Behavior Towards Products and Brands: Introduction to a Journal of Brand Management Special Issue

    Get PDF
    This introduction reviews the motivating forces behind this issue, exploring the role of nonconscious consumer behavior in branding environments. The article establishes a foundation of unconscious research in psychology and consumer behavior, and then provides an introduction to the four articles that follow. The article concludes with a call to adopt an inclusive interpretive-positivistic stance to the study of unconscious consumer-brand behavior, attitudes and beliefs

    Discovery of a new class of inhibitors for the protein arginine deiminase type 4 (PAD4) by structure-based virtual screening

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Rheumatoid arthritis (RA) is an autoimmune disease with unknown etiology. Anticitrullinated protein autoantibody has been documented as a highly specific autoantibody associated with RA. Protein arginine deiminase type 4 (PAD4) is the enzyme responsible for catalyzing the conversion of peptidylarginine into peptidylcitrulline. PAD4 is a new therapeutic target for RA treatment. In order to search for inhibitors of PAD4, structure-based virtual screening was performed using LIDAEUS (Ligand discovery at Edinburgh university). Potential inhibitors were screened experimentally by inhibition assays.</p> <p>Results</p> <p>Twenty two of the top-ranked water-soluble compounds were selected for inhibitory screening against PAD4. Three compounds showed significant inhibition of PAD4 and their IC<sub>50 </sub>values were investigated. The structures of the three compounds show no resemblance with previously discovered PAD4 inhibitors, nor with existing drugs for RA treatment.</p> <p>Conclusion</p> <p>Three compounds were discovered as potential inhibitors of PAD4 by virtual screening. The compounds are commercially available and can be used as scaffolds to design more potent inhibitors against PAD4.</p

    Mind Perception Is the Essence of Morality

    Get PDF
    Mind perception entails ascribing mental capacities to other entities, whereas moral judgment entails labeling entities as good or bad or actions as right or wrong. We suggest that mind perception is the essence of moral judgment. In particular, we suggest that moral judgment is rooted in a cognitive template of two perceived minds—a moral dyad of an intentional agent and a suffering moral patient. Diverse lines of research support dyadic morality. First, perceptions of mind are linked to moral judgments: dimensions of mind perception (agency and experience) map onto moral types (agents and patients), and deficits of mind perception correspond to difficulties with moral judgment. Second, not only are moral judgments sensitive to perceived agency and experience, but all moral transgressions are fundamentally understood as agency plus experienced suffering—that is, interpersonal harm—even ostensibly harmless acts such as purity violations. Third, dyadic morality uniquely accounts for the phenomena of dyadic completion (seeing agents in response to patients, and vice versa), and moral typecasting (characterizing others as either moral agents or moral patients). Discussion also explores how mind perception can unify morality across explanatory levels, how a dyadic template of morality may be developmentally acquired, and future directions

    Rheumatoid arthritis - treatment: 180. Utility of Body Weight Classified Low-Dose Leflunomide in Japanese Rheumatoid Arthritis

    Get PDF
    Background: In Japan, more than 20 rheumatoid arthritis (RA) patients died of interstitial pneumonia (IP) caused by leflunomide (LEF) were reported, but many of them were considered as the victims of opportunistic infection currently. In this paper, efficacy and safety of low-dose LEF classified by body weight (BW) were studied. Methods: Fifty-nine RA patients were started to administrate LEF from July 2007 to July 2009. Among them, 25 patients were excluded because of the combination with tacrolimus, and medication modification within 3 months before LEF. Remaining 34 RA patients administered 20 to 50 mg/week of LEF were followed up for 1 year and enrolled in this study. Dose of LEF was classified by BW (50 mg/week for over 50 kg, 40 mg/week for 40 to 50 kg and 20 to 30 mg/week for under 40 kg). The average age and RA duration of enrolled patients were 55.5 years old and 10.2 years. Prednisolone (PSL), methotrexate (MTX) and etanercept were used in 23, 28 and 2 patients, respectively. In case of insufficient response or adverse effect, dosage change or discontinuance of LEF were considered. Failure was defined as dosages up of PSL and MTX, or dosages down or discontinuance of LEF. Last observation carried forward method was used for the evaluation of failed patients at 1 year. Results: At 1 year after LEF start, good/ moderate/ no response assessed by the European League Against Rheumatism (EULAR) response criteria using Disease Activity Score, including a 28-joint count (DAS28)-C reactive protein (CRP) were showed in 14/ 10/ 10 patients, respectively. The dosage changes of LEF at 1 year were dosage up: 10, same dosage: 5, dosage down: 8 and discontinuance: 11 patients. The survival rate of patients in this study was 23.5% (24 patients failed) but actual LEF continuous rate was 67.6% (11 patients discontinued) at 1 year. The major reason of failure was liver dysfunction, and pneumocystis pneumonia was occurred in 1 patient resulted in full recovery. One patient died of sepsis caused by decubitus ulcer infection. DAS28-CRP score was decreased from 3.9 to 2.7 significantly. Although CRP was decreased from 1.50 to 0.93 mg/dl, it wasn't significant. Matrix metalloproteinase (MMP)-3 was decreased from 220.0 to 174.2 ng/ml significantly. Glutamate pyruvate transaminase (GPT) was increased from 19 to 35 U/l and number of leukocyte was decreased from 7832 to 6271 significantly. DAS28-CRP, CRP, and MMP-3 were improved significantly with MTX, although they weren't without MTX. Increase of GPT and leukopenia were seen significantly with MTX, although they weren't without MTX. Conclusions: It was reported that the risks of IP caused by LEF in Japanese RA patients were past IP history, loading dose administration and low BW. Addition of low-dose LEF is a potent safe alternative for the patients showing unsatisfactory response to current medicines, but need to pay attention for liver function and infection caused by leukopenia, especially with MTX. Disclosure statement: The authors have declared no conflicts of interes
    corecore